<html xmlns:o="urn:schemas-microsoft-com:office:office" xmlns:w="urn:schemas-microsoft-com:office:word" xmlns:m="http://schemas.microsoft.com/office/2004/12/omml" xmlns="http://www.w3.org/TR/REC-html40">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=iso-8859-1">
<meta name="Generator" content="Microsoft Word 15 (filtered medium)">
<style><!--
/* Font Definitions */
@font-face
{font-family:Wingdings;
panose-1:5 0 0 0 0 0 0 0 0 0;}
@font-face
{font-family:"Cambria Math";
panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
{font-family:Calibri;
panose-1:2 15 5 2 2 2 4 3 2 4;}
@font-face
{font-family:"Calibri Light";
panose-1:2 15 3 2 2 2 4 3 2 4;}
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
{margin:0cm;
font-size:11.0pt;
font-family:"Calibri",sans-serif;}
h2
{mso-style-priority:9;
mso-style-link:"Rubrik 2 Char";
margin-top:2.0pt;
margin-right:0cm;
margin-bottom:0cm;
margin-left:0cm;
page-break-after:avoid;
font-size:13.0pt;
font-family:"Calibri Light",sans-serif;
color:#2F5496;
font-weight:normal;}
h3
{mso-style-priority:9;
mso-style-link:"Rubrik 3 Char";
margin-top:2.0pt;
margin-right:0cm;
margin-bottom:0cm;
margin-left:0cm;
page-break-after:avoid;
font-size:12.0pt;
font-family:"Calibri Light",sans-serif;
color:#1F3763;
font-weight:normal;}
a:link, span.MsoHyperlink
{mso-style-priority:99;
color:#0563C1;
text-decoration:underline;}
span.Rubrik2Char
{mso-style-name:"Rubrik 2 Char";
mso-style-priority:9;
mso-style-link:"Rubrik 2";
font-family:"Calibri Light",sans-serif;
color:#2F5496;}
span.Rubrik3Char
{mso-style-name:"Rubrik 3 Char";
mso-style-priority:9;
mso-style-link:"Rubrik 3";
font-family:"Calibri Light",sans-serif;
color:#1F3763;}
span.notranslate
{mso-style-name:notranslate;}
.MsoChpDefault
{mso-style-type:export-only;}
@page WordSection1
{size:612.0pt 792.0pt;
margin:70.85pt 70.85pt 70.85pt 70.85pt;}
div.WordSection1
{page:WordSection1;}
/* List Definitions */
@list l0
{mso-list-id:238369511;
mso-list-type:hybrid;
mso-list-template-ids:-32478150 -1 69009411 69009413 69009409 69009411 69009413 69009409 69009411 69009413;}
@list l0:level1
{mso-level-start-at:0;
mso-level-number-format:bullet;
mso-level-text:-;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-18.0pt;
font-family:"Calibri",sans-serif;
mso-fareast-font-family:"Times New Roman";}
@list l0:level2
{mso-level-number-format:bullet;
mso-level-text:o;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-18.0pt;
font-family:"Courier New";}
@list l0:level3
{mso-level-number-format:bullet;
mso-level-text:\F0A7;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-18.0pt;
font-family:Wingdings;}
@list l0:level4
{mso-level-number-format:bullet;
mso-level-text:\F0B7;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-18.0pt;
font-family:Symbol;}
@list l0:level5
{mso-level-number-format:bullet;
mso-level-text:o;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-18.0pt;
font-family:"Courier New";}
@list l0:level6
{mso-level-number-format:bullet;
mso-level-text:\F0A7;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-18.0pt;
font-family:Wingdings;}
@list l0:level7
{mso-level-number-format:bullet;
mso-level-text:\F0B7;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-18.0pt;
font-family:Symbol;}
@list l0:level8
{mso-level-number-format:bullet;
mso-level-text:o;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-18.0pt;
font-family:"Courier New";}
@list l0:level9
{mso-level-number-format:bullet;
mso-level-text:\F0A7;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-18.0pt;
font-family:Wingdings;}
ol
{margin-bottom:0cm;}
ul
{margin-bottom:0cm;}
--></style>
</head>
<body lang="SV" link="#0563C1" vlink="#954F72" style="word-wrap:break-word">
<div class="WordSection1">
<p class="MsoNormal"><o:p> </o:p></p>
<h2>This years Bio+MedVis challenge is up! <span style="font-size:11.0pt"><o:p></o:p></span></h2>
<h2 style="mso-margin-top-alt:10.0pt;margin-right:0cm;margin-bottom:7.0pt;margin-left:0cm">
<b><span style="font-size:17.0pt;font-family:"Arial",sans-serif;color:#2C3E50">Taming protein beasts through visualization</span></b><o:p></o:p></h2>
<p class="MsoNormal" style="mso-margin-top-alt:12.0pt;margin-right:0cm;margin-bottom:12.0pt;margin-left:0cm">
<span style="font-size:12.0pt;font-family:"Arial",sans-serif;color:#2C3E50">How do 3D protein modifications relate to rare disease?</span><o:p></o:p></p>
<h3 style="margin-top:8.0pt"><b><span style="font-size:13.0pt;font-family:"Arial",sans-serif;color:#2C3E50">Goal</span></b><o:p></o:p></h3>
<p class="MsoNormal" style="mso-margin-top-alt:12.0pt;margin-right:0cm;margin-bottom:12.0pt;margin-left:0cm">
<span style="font-size:12.0pt;font-family:"Arial",sans-serif;color:#2C3E50">Understanding chemical modifications on the 3D structure of proteins has the potential to unlock cures for myriad rare diseases. This year, we provide a unique dataset of different
types of new protein modifications. <b>We want your help</b> to visually understand where
<i>protein modifications</i> are most likely to occur, and whether these are in loci with known connections to specific rare diseases.</span><o:p></o:p></p>
<h3 style="margin-top:8.0pt"><b><span style="font-size:13.0pt;font-family:"Arial",sans-serif;color:#2C3E50"><o:p> </o:p></span></b></h3>
<p class="MsoNormal"><span style="font-family:"Arial",sans-serif;color:black">Get the data and more information at
<a href="http://biovis.net/2022/biovisChallenges_vis/">http://biovis.net/2022/biovisChallenges_vis/</a></span><o:p></o:p></p>
<p class="MsoNormal"><o:p> </o:p></p>
<h3 style="margin-top:8.0pt"><b><span style="font-size:13.0pt;font-family:"Arial",sans-serif;color:#2C3E50">Submission</span></b><o:p></o:p></h3>
<p class="MsoNormal" style="mso-margin-top-alt:12.0pt;margin-right:0cm;margin-bottom:12.0pt;margin-left:0cm">
<span style="font-size:12.0pt;font-family:"Arial",sans-serif;color:#2C3E50">Submissions will be considered for talk or poster presentations. Please send a two-page PDF abstract with unlimited additional figures and a draft of your proposed poster (max 10MB)
to biovis_challenge@ieeevis.org latest on September 1st 2022 (anywhere on earth). The abstract should include:</span><o:p></o:p></p>
<ul style="margin-top:0cm;padding-inline-start:48px" type="disc">
<li class="MsoNormal" style="color:#2C3E50;margin-top:12.0pt;mso-list:l0 level1 lfo1;vertical-align:baseline">
<span style="font-size:12.0pt;font-family:"Arial",sans-serif">aspects of the figure identified as needing improvement or clarification,<o:p></o:p></span></li><li class="MsoNormal" style="color:#2C3E50;mso-list:l0 level1 lfo1;vertical-align:baseline">
<span style="font-size:12.0pt;font-family:"Arial",sans-serif">justification of encoding and design choices,<o:p></o:p></span></li><li class="MsoNormal" style="color:#2C3E50;mso-list:l0 level1 lfo1;vertical-align:baseline">
<span style="font-size:12.0pt;font-family:"Arial",sans-serif">at least one or more images of your design<o:p></o:p></span></li><li class="MsoNormal" style="color:#2C3E50;margin-bottom:12.0pt;mso-list:l0 level1 lfo1;vertical-align:baseline">
<span style="font-size:12.0pt;font-family:"Arial",sans-serif">optional: a video or screencast to explain the visual encoding<o:p></o:p></span></li></ul>
<p class="MsoNormal" style="mso-margin-top-alt:12.0pt;margin-right:0cm;margin-bottom:12.0pt;margin-left:0cm">
<span style="font-size:12.0pt;font-family:"Arial",sans-serif;color:#2C3E50">Last year, the acceptance rate for presentations happened to be 100%, yet such acceptance rate is not guaranteed. Selected submissions will be invited for talk presentations during
the Bio+MedVis session within the </span><a href="http://ieeevis.org/"><span class="notranslate"><span style="font-size:12.0pt;font-family:"Arial",sans-serif;color:#1155CC;text-decoration:none">IEEE VIS 2022</span></span></a><span style="font-size:12.0pt;font-family:"Arial",sans-serif;color:#2C3E50">
conference.</span><o:p></o:p></p>
<h3 style="margin-top:8.0pt"><b><span style="font-size:13.0pt;font-family:"Arial",sans-serif;color:#2C3E50">Questions?</span></b><o:p></o:p></h3>
<p class="MsoNormal" style="mso-margin-top-alt:12.0pt;margin-right:0cm;margin-bottom:12.0pt;margin-left:0cm">
<span style="font-size:12.0pt;font-family:"Arial",sans-serif;color:#2C3E50">Please feel free to ask questions on
<a href="https://biovis2016.slack.com/">our Slack channel #biovis-challenge2022</a> if you need more information and details about the data or tasks.</span><o:p></o:p></p>
<p class="MsoNormal"><o:p> </o:p></p>
</div>
</body>
</html>